ARCHIVES

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.

September 29, 2000

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

ACS Honors Cady, Rimer For Work In Cancer Control.

December 8, 2000

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991